Mr. Almiro is a Managing Director at Quantum Health Advisors, LLC and is based in Dallas, Texas. He applies over 25 years of corporate finance, institutional investing, financial valuation, and accounting experience to advise clients and counsel on complex financial, accounting, valuation, and damage matters. His experience spans several industries, with a particular focus on the healthcare sector.

Mr. Almiro is a Chartered Financial Analyst (CFA), Certified Public Accountant (CPA) and earned an MBA from the University of Notre Dame and a Bachelors of Science in Accounting from Marquette University. He frequently speaks at conferences and educational forums, where he addresses topics related to finance, accounting, and valuation. Additionally, he has published articles for industry journals.

CORPORATE FINANCE EXPERIENCE
Mr. Almiro has experience originating, structuring, negotiating, and underwriting over $1 billion of senior secured corporate loans within the healthcare industry. His experience includes conducting detailed industry analyses to identify key trends, regulatory changes, and market dynamics affecting various sectors. At the company level, Mr. Almiro has extensive experience in conducting comprehensive credit analyses to evaluate the financial health and stability of companies. These analyses routinely involve assessing financial statements, cash flow projections, and balance sheet metrics to gauge profitability, liquidity, and solvency. Mr. Almiro has experience evaluating a company’s operational efficiency, management team expertise, and strategic initiatives to assess business sustainability and growth prospects. Within the healthcare industry, he has extensive experience assessing factors such as reimbursement methodologies (fee-for-service, capitation, bundled payment, and value-based care), reimbursement rates, revenue cycle management practices (coding, billing, claims, and collections), contractual agreements (physicians, commercial payers, and strategic partnerships) and regulatory compliance.
Mr. Almiro has routinely advised the Board of Directors at a $50 billion bank holding company on healthcare legislative, regulatory, reimbursement, and sector-specific issues. He has published leading Thought Leadership on healthcare industry issues and presented at numerous conferences.

INSTITUTIONAL INVESTING EXPERIENCE
Mr. Almiro has experience identifying, analyzing, and managing a portfolio of broadly syndicated, below investment-grade, senior secured leveraged loans for institutional investors. Mr. Almiro has experience conducting both top-down and bottom-up fundamental analyses to identify attractive loan opportunities. Mr. Almiro has conducted macroeconomic and sector-specific analyses to identify attractive industries and sectors for investment. Mr. Almiro’s institutional investing experience spans across several industries, with a focus on the healthcare services and facilities, pharmaceutical and life sciences, health insurance and managed care, information technology and digital health, and medical device and equipment sectors.

Mr. Almiro has conducted detailed and comprehensive fundamental analysis on numerous companies. This involves extensive financial and accounting due diligence, scrutinizing financial statements, credit history, and overall business fundamentals. He has evaluated companies’ financial health, operational performance, competitive positioning, and growth prospects. He has scrutinized key factors such as revenue growth potential, profitability margins, cash flow generation, and debt repayment capacity. He has also negotiated and assessed the specific terms and structure of loans, including covenants and collateral coverage.

FINANCIAL VALUATION, DAMAGES, AND ACCOUNTING EXPERIENCE
Mr. Almiro applies over 25 years of corporate finance, institutional investing, financial valuation and accounting experience to advise clients and counsel on complex financial valuation, damage calculation, and accounting matters.

Mr. Almiro has issued independent and defensible financial valuation opinions and calculated economic damages for clients and counsel. He has conducted in-depth analyses of financial statements, tax records, and transactional data to assess the financial performance, profitability, liquidity, and solvency of businesses under examination. Furthermore, Mr. Almiro has evaluated the methodologies used for financial valuation, ensuring adherence to industry standards and best practices.

Mr. Almiro has provided damage calculation analyses to quantify economic losses or damages sustained. He has assessed the financial impact of contractual breaches, billing irregularities, business interruptions, regulatory non-compliance, and intellectual property infringements, employing financial modeling and forensic accounting to identify and quantify damages. Additionally, he has provided opinions on complex accounting issues and financial reporting irregularities.

Within the healthcare industry, Mr. Almiro has experience with numerous reimbursement models (including fee-for-service, capitation, bundled payment, and value-based care), government cost reporting, revenue cycle management practices (such as coding, billing, claims, and collections), contractual agreements (involving physicians, commercial payers, and strategic partnerships), and regulatory compliance.